Guillermo Garcia-Manero | MD Anderson ...

Dr. Guillermo Garcia-Manero

Claim this profile

M D Anderson Cancer Center

Expert in Myelodysplastic Syndrome
Studies Chronic Myelomonocytic Leukemia
20 reported clinical trials
23 drugs studied

Area of expertise

1

Myelodysplastic Syndrome

Global Leader

Guillermo Garcia-Manero has run 18 trials for Myelodysplastic Syndrome. Some of their research focus areas include:

SF3B1 positive
U2AF1 positive
FLT3 positive
2

Chronic Myelomonocytic Leukemia

Guillermo Garcia-Manero has run 6 trials for Chronic Myelomonocytic Leukemia. Some of their research focus areas include:

del 5q positive

Affiliated Hospitals

Image of trial facility.

M D Anderson Cancer Center

Image of trial facility.

University Of Texas MD Anderson Cancer Center

Clinical Trials Guillermo Garcia-Manero is currently running

More about Guillermo Garcia-Manero

Clinical Trial Related

4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 6 Active Clinical Trials

Treatments Guillermo Garcia-Manero has experience with

  • Azacitidine
  • Venetoclax
  • MBG453
  • Canakinumab
  • Luspatercept
  • Nivolumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Guillermo Garcia-Manero specialize in?

Is Guillermo Garcia-Manero currently recruiting for clinical trials?

Are there any treatments that Guillermo Garcia-Manero has studied deeply?

What is the best way to schedule an appointment with Guillermo Garcia-Manero?

What is the office address of Guillermo Garcia-Manero?

Is there any support for travel costs?